Cell by Design®: a quality-focused process development roadmap for ATMPs

12/7/2019 - Stephanie Verwimp, Marketing & Communication Manager

Since ATMPs (Advanced Therapy Medical Products) is one of our two focal points (next to Medical Devices), we’re proud to announce Cell by Design® (CbD)…

Read more

Focal point update: Car-T Therapy refundable as of today!

4/6/2019 - Stephanie Verwimp, Marketing & Communication Manager

As ATMPs (Advanced Therapy Medicinal Products) are one of our focal points, we are obviously very happy with the news that the Belgian minister of…

Read more

QbD Event: Advanced & Breakthrough therapies, from idea to patient

17/4/2019 - Stephanie Verwimp, Marketing & Communication Manager

Together with our partners Antleron, Inovigate, Eye-Tec, Neuroplast and Anicells, we’re organizing an event on ATMPs on June 13. We would like to invite everyone…

Read more

Belgium as pioneer in ATMPs: now and in the future

11/4/2019 - Jan Schrooten, co-founder and CEO at Antleron

Backed by increasing investments from commercial sponsors, the development of advanced therapy medicinal products (ATMPs) is growing strongly in the United Kingdom. For good reason,…

Read more

QbD’s services and focal points anno 2019

26/3/2019 - Stephanie Verwimp, Marketing & Communication Manager

During 2018 we organized an intern strategic meeting to set up the goals, concerning the next few years of QbD and to decide which concrete…

Read more

ATMPs in a nutshell: what you should know about classification, quality and go to market

6/3/2019 - Wim Steenackers Business Development Manager at Quality by design

Advanced therapy medicinal products (ATMPs) is the group of therapies in which we use cells, genes, engineered tissues and combinations of the above with medical…

Read more

Our Health & 3D printing: a match made in heaven?

3/11/2018 - Charlotte De Vriendt, Pharmaceutical Consultant at QbD

In recent years, 3D printing techniques have been revolutionising the healthcare industry everywhere in the world. 3D printing has the ability to print personalised medical…

Read more

Pioneering with Artificial Intelligence to make personalized cell therapy more accessible

29/8/2018 - Evan Claes, R&D Engineer at Antleron

Several scientific and clinical breakthroughs of our past decade show that Advanced Therapy Medicinal Products (ATMPs) will revolutionize 21st century medicine. By using cells as…

Read more

Antleron & QbD team up to create a landslide in healthcare

11/5/2017 - Martijn Reniers, Managing Partner at Quality by Design

A whole new era in healthcare is coming closer every day. Thanks to the crossover of 3D printing and biology, medical solutions will be personalised…

Read more